BioVie Inc

BioVie Inc a clinical stage biotechnology company engages in the discovery development and commercialization of drugs therapies in the United States Its products in pipeline include BIV201 which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis and NE3107 which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimers disease and Phase I clinical trial for the treatment of Parkinsons disease The company is also developing NE3107 which is in preclinical stage for the treatment of multiple myeloma and prostate cancer The company was formerly known as NanoAntibiotics Inc and changed its name to BioVie Inc in July 2016 BioVie Inc was incorporated in 2013 and is based in Carson City Nevada